The first reports of coronavirus — a group of viruses that includes COVID-19 and other diseases — go back to the 1930s.

In a recent study published in the Journal of Medical Virology, researchers analyzed the efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in preventing SARS-CoV-2 ...

Unraveling mechanisms underlying post-acute SARS-CoV-2 sequelae (long COVID) and finding therapeutic solutions require a full understanding of the causative role of SARS-CoV-2 persistence and/or ...

In a recent study posted to the bioRxiv* preprint server, researchers investigated whether immunity against seasonal human coronavirus (CoV) spike (S) proteins of HKU1, OC43, NL63, or 229E could ...

The incubation period for COVID-19—the time between when SARS-CoV-2 first infects a person and when resulting COVID-19 symptoms first appear—has gradually shortened as the pandemic has stretched on ...

Offspring of SARS-CoV-2-exposed pregnancies received a neurodevelopmental diagnosis by 36 months more often than unexposed offspring.

Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that confer escape from neutralizing antibodies can arise in immunocompromised patients with prolonged ...

While various biopharmas are working on vaccines that could protect against multiple strains of COVID-19, researchers in the U.S. have reported early success in a shot that goes even further—offering ...

SARS-CoV-2 is the etiologic agent of COVID-19 and one of three types of Coronavirus that cause Severe Acute Respiratory Syndrome (SARS). SARS-CoV-2 undergoes mutation at a rapid rate, which leads to ...

The aftermath of the corona pandemic is far from over, and theoretical successors are already emerging among biologists. Scientists have discovered new coronaviruses in bats in Brazil that could jump ...